The report provides a detailed analysis essential for establishing a Leuprolide production plant. It encompasses all critical aspects necessary for Leuprolide production, including the cost of Leuprolide production, Leuprolide plant cost, Leuprolide production costs, and the overall Leuprolide production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Leuprolide production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Leuprolide is a pharmacologically active synthetic peptide that finds applications primarily in the field of medicine, particularly in hormone-related therapies. It is mainly used in the treatment of hormone-dependent conditions, such as prostate cancer, endometriosis, uterine fibroids, and precocious puberty, by regulating the release of gonadotropins and controlling hormone levels. Additionally, it is also used in assisted reproductive technologies to manage ovulation and improve the success of fertility treatments. It also finds some applications as a compound in clinical research for studying reproductive endocrinology and hormonal therapies.
The market for Leuprolide is predominantly driven by its application as a valuable drug in the management of hormone-dependent disorders and reproductive health, which promotes its demand in the medical sector. Its application as a hormone-regulating medication for conditions such as prostate cancer, endometriosis, and uterine fibroids significantly boosts its demand in the healthcare and pharmaceutical industries. Its utilisation as a drug in assisted reproductive technologies to help manage ovulation further increases its demand in the fertility treatment sector.
Its demand in long-term hormone therapy and its consistent use in hospital and clinical settings largely contribute to its overall market growth. Several factors influence industrial Leuprolide procurement, including the availability and cost of essential raw materials, production efficiency, regulatory compliance, and adherence to strict pharmaceutical quality and safety standards. Moreover, advancements in peptide synthesis technologies, supply chain reliability, environmental guidelines, sustainability practices, and effective logistics and distribution networks play an important role in shaping the global procurement processes for Leuprolide.
Raw Material for Leuprolide Production
According to the Leuprolide production plant project report, the major raw materials for Leuprolide production include two peptide fragments: H-Leu-Arg(NO2)-Pro-NHCH2CH3 and Pyr-His-Trp-Ser-Tyr-OH, and Coupling reagents- DCC (N,N’-Dicyclohexylcarbodiimide) and HONB (N-hydroxy-5-norbornene-2,3-dicarboximide).
Production Process of Leuprolide
The extensive Leuprolide production cost report consists of the following industrial production process:
- Production via Fragment based Peptide Synthesis Route: The production process of leuprolide begins with the preparation of two peptide fragments, H-Leu-Arg(NO2)-Pro-NHCH2CH3 and Pyr-His-Trp-Ser-Tyr-OH. In these peptide fragments, the N-terminus and the guanidinium group of arginine are protected only, while the other side chains are unprotected. The first fragment is extended by coupling with Z-D-Leu-OH using DCC and HONB activation to form Z-D-Leu-Leu-Arg(NO2)-Pro-NHCH2CH3. This is followed by the removal of the Z-protecting group with hydrobromic acid in acetic acid to produce the free amine fragment. Then, the second fragment is activated with DCC-HONB and condensed with the free amine fragment to produce the full-length nitro-protected leuprolide. Finally, the nitro protecting group is removed using aqueous formic acid and tin(II) chloride, producing the final active peptide, leuprolide, in its functional form, as the product.
Leuprolide is a pharmacologically active peptide that exists as a white to off-white, fluffy or crystalline powder with little to no odour. Its molecular formula (free base) is C59H84N16O12, and its molar mass is approximately 1209.4 g/mol. The compound is very soluble in water and aqueous buffers, but poorly soluble in most nonpolar organic solvents. It decomposes before a clear melting point, and has no well-defined boiling point or flash point due to thermal instability. It is a synthetic nonapeptide analogue of gonadotropin-releasing hormone (GnRH), which functions as a potent GnRH agonist. It must be handled with care, and its exposure may lead to endocrine and reproductive effects, so appropriate protective measures (e.g., gloves, lab coat) are strongly advised.